首页> 外文会议>Biotech, biomaterials and biomedical >Production of NSAID pharmaceutical molecular liquids via RESS processing
【24h】

Production of NSAID pharmaceutical molecular liquids via RESS processing

机译:通过RESS加工生产NSAID药物分子液体

获取原文
获取原文并翻译 | 示例

摘要

We report the production of pharmaceutical molecular clusters of most commonly implemented and prominent drug molecules such as ibuprofen and naproxen, via Rapid Expansion of Supercritical Solution (RESS) processing under mild conditions. These drug molecular clusters were first trapped in "dry ice" and subsequently solubilized in DI water under ambient conditions. These solutions are found to be stable over a period of several weeks. Drop casting and ambient drying of these solutions on a silicon substrate resulted in stable, viscous liquid films. Optical and electron microscopy showed typical liquid like behavior of these drop casted films. In-vitro cell viability studies, clearly demonstrated that the water-solubilized ibuprofen and naproxen exhibit similar cytotoxicity to the as received, raw drug powders thus retaining their original potency.
机译:我们报告了通过在温和条件下快速扩展超临界溶液(RESS)处理,生产出最常用的和最常用的药物分子,例如布洛芬和萘普生的药物分子簇。这些药物分子簇首先被捕获在“干冰”中,然后在环境条件下溶解在去离子水中。发现这些溶液在几周内是稳定的。将这些溶液滴铸并在硅基板上进行室温干燥,得到稳定的粘稠液体薄膜。光学和电子显微镜显示这些滴延流延膜的典型液体状行为。体外细胞生存力研究清楚地表明,水溶解的布洛芬和萘普生显示出与原始药物粉末相似的细胞毒性,因此保留了其原始效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号